LARRY CRISP: Open Payments
NPI 1275693921 · DECATUR, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 63 payments from 14 companies in 2025. Trend: 2023 $824 · 2024 $666 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $244 |
| ABBVIE INC. | 13 | $161 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Phathom Pharmaceuticals, Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| Medtronic, Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $47 |
| PFIZER INC. | 3 | $46 |
| Lilly USA, LLC | 2 | $45 |
Products named: CAPLYTA, VRAYLAR, REXULTI, AIRSUPRA, VOQUEZNA, Auvelity, NURTEC ODT, JARDIANCE.
Industry payments across TN — which companies pay providers there.
